BSE filing, NSE: PARADEEP. Summary written from the filing by ALFA Finder's alert engine.
Paradeep Phosphates Ltd: key numbers
- Share price
- ₹138.19
- Market cap
- ₹14,351 Cr
- Revenue (annual)
- ₹21,826 Cr
- Net profit (annual)
- ₹996.4 Cr
- P/E (TTM)
- 13.4×Sector 9.6×
- Promoter holding
- 57.85%-0.01% QoQ
- FII holding
- 4.79%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Paradeep Phosphates Ltd
All →Paradeep Phosphates Board Meeting Date
Paradeep Phosphates informed exchanges that its Board is scheduled to meet on 29 Oct 2026 to consider unaudited Q1 and H1 results. The trading window remains closed till 31 Oct 2026.
Paradeep Phosphates Capacity Expansion: ₹4,750 Cr Investment
Paradeep Phosphates signed an MoU with Odisha Govt for ₹4,750 Cr investment in new chemical and fertilizer plants. The expansion adds a chemical plant and bio-fertilizers facility.
- Value
- ₹4,750 Cr
Paradeep Phosphates Management Change
Paradeep Phosphates Limited has appointed Mr. Raj Kumar Agrawal as an Additional Independent Director for a five-year term, effective October 13, 2026.
Paradeep Phosphates Other Announcement
Paradeep Phosphates filed its quarterly compliance certificate under Regulation 74(5) of SEBI regulations, as received from its Share Transfer Agent.
Paradeep Phosphates Annual General Meeting
Paradeep Phosphates held its 44th Annual General Meeting on September 17, 2026, to transact various business items including dividend declaration and approval of stock option plans.
Paradeep Phosphates Other Announcement
Paradeep Phosphates Limited submitted its Business Responsibility and Sustainability Report for the financial year 2025-26. This filing fulfills periodic regulatory compliance requirements under SEBI LODR Regulation 34.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date